OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ZAB$25.6059

Zabka Group SA

Food Retail & DistributionVerified

Zabka Group SA maintains a capital structure with a debt-to-equity ratio of 3.79, indicating a significant reliance on debt financing. The company's liquidity position is characterized by a current ratio of 0.63, suggesting potential short-term liquidity constraints. The company's liquidity FPT (free cash flow to total liabilities) is weak, with free cash flow of 1.32 billion PLN against total liabilities of 17.02 billion PLN. In terms of profitability, Zabka Group SA reports a return on equity (ROE) of 44.17% and a return on assets (ROA) of 5.65%. These figures are strong compared to the industry median for ROE, but the ROA is in line with the industry average. The company's operating margin is 7.31%, which is slightly above the industry median, indicating efficient cost management. Zabka Group SA's revenue is primarily concentrated in its domestic market, with no significant international revenue disclosed. The company operates through a single business segment, which may increase its exposure to regional economic fluctuations. The lack of geographic diversification could pose a risk in the event of local economic downturns. The company's growth trajectory is expected to remain stable, with revenue growth projected to be in line with the industry average. The company's free cash flow of 1.32 billion PLN supports its capital expenditure of 1.62 billion PLN, indicating a focus on maintaining and expanding its retail infrastructure. The company's operating cash flow of 4.11 billion PLN provides a buffer for future investments. Zabka Group SA faces moderate liquidity risk due to its current ratio of 0.63 and a debt-to-equity ratio of 3.79. The company's net cash position is negative after subtracting total debt, which could necessitate additional financing in the future. The risk assessment indicates a low probability of dilution, with no significant dilution sources identified in the recent filings. Recent events, including analyst estimates and price targets, suggest a generally positive outlook for the company. The mean price target of 26.28 PLN and the median price target of 27.00 PLN indicate that analysts expect the stock to perform slightly above its current market price of 25.6 PLN. The mean recommendation of 2.25 (on a scale from 1 to 5) suggests a mixed but generally positive sentiment among analysts.

30-day price · ZAB+1.70 (+7.4%)
Low$22.30High$25.86Close$24.80As of25 May, 00:00 UTC
Profile
CompanyZabka Group SA
TickerZAB.WA
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Zabka Group SA operates in the food retail and distribution sector, generating revenue primarily through the operation of retail stores and the sale of food and drug products.

Classification. Zabka Group SA is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a classification confidence of 0.92.

Zabka Group SA maintains a capital structure with a debt-to-equity ratio of 3.79, indicating a significant reliance on debt financing. The company's liquidity position is characterized by a current ratio of 0.63, suggesting potential short-term liquidity constraints. The company's liquidity FPT (free cash flow to total liabilities) is weak, with free cash flow of 1.32 billion PLN against total liabilities of 17.02 billion PLN. In terms of profitability, Zabka Group SA reports a return on equity (ROE) of 44.17% and a return on assets (ROA) of 5.65%. These figures are strong compared to the industry median for ROE, but the ROA is in line with the industry average. The company's operating margin is 7.31%, which is slightly above the industry median, indicating efficient cost management. Zabka Group SA's revenue is primarily concentrated in its domestic market, with no significant international revenue disclosed. The company operates through a single business segment, which may increase its exposure to regional economic fluctuations. The lack of geographic diversification could pose a risk in the event of local economic downturns. The company's growth trajectory is expected to remain stable, with revenue growth projected to be in line with the industry average. The company's free cash flow of 1.32 billion PLN supports its capital expenditure of 1.62 billion PLN, indicating a focus on maintaining and expanding its retail infrastructure. The company's operating cash flow of 4.11 billion PLN provides a buffer for future investments. Zabka Group SA faces moderate liquidity risk due to its current ratio of 0.63 and a debt-to-equity ratio of 3.79. The company's net cash position is negative after subtracting total debt, which could necessitate additional financing in the future. The risk assessment indicates a low probability of dilution, with no significant dilution sources identified in the recent filings. Recent events, including analyst estimates and price targets, suggest a generally positive outlook for the company. The mean price target of 26.28 PLN and the median price target of 27.00 PLN indicate that analysts expect the stock to perform slightly above its current market price of 25.6 PLN. The mean recommendation of 2.25 (on a scale from 1 to 5) suggests a mixed but generally positive sentiment among analysts.
Key takeaways
  • Zabka Group SA has a strong return on equity (44.17%) but a moderate return on assets (5.65%).
  • The company's liquidity position is weak, with a current ratio of 0.63 and a debt-to-equity ratio of 3.79.
  • Revenue is concentrated in a single geographic market, increasing exposure to regional economic risks.
  • Analysts have a generally positive outlook, with a mean price target of 26.28 PLN and a median price target of 27.00 PLN.
  • --
  • ## RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyPLN
Revenue$27.15B
Gross profit$5.10B
Operating income$1.99B
Net income$1.10B
R&D
SG&A
D&A
SBC
Operating cash flow$4.11B
CapEx-$1.62B
Free cash flow$1.32B
Total assets$19.51B
Total liabilities$17.02B
Total equity$2.49B
Cash & equivalents$1.08B
Long-term debt$9.45B
Valuation
Market price$25.60
Market cap$25.58B
Enterprise value$33.95B
P/E23.2
Reported non-GAAP P/E
EV/Revenue1.2
EV/Op income17.1
EV/OCF8.3
P/B10.3
P/Tangible book10.3
Tangible book$2.49B
Net cash-$8.37B
Current ratio0.6
Debt/Equity3.8
ROA5.7%
ROE44.2%
Cash conversion3.7%
CapEx/Revenue-6.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricZABActivity
Op margin7.3%3.1% medp25 1.2% · p75 6.8%top quartile
Net margin4.1%2.0% medp25 0.7% · p75 4.1%top quartile
Gross margin18.8%26.1% medp25 17.2% · p75 32.0%below median
CapEx / revenue-6.0%-2.5% medp25 -4.6% · p75 -1.4%bottom quartile
Debt / equity379.0%56.0% medp25 16.8% · p75 121.1%top quartile
Observations
IR observations
Mean price target26.28 PLN
Median price target27.00 PLN
High price target31.00 PLN
Low price target19.60 PLN
Mean recommendation2.25 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count8.00
Hold count4.00
Sell count0.00
Strong-sell count1.00
Mean EPS estimate1.21 PLN
Last actual EPS0.91 PLN
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-25 04:57 UTC#93c66074
Source: analysis-pipeline (hybrid)Generated: 2026-05-30 03:03 UTCJob: 58b4e688